Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

K-V names permanent CEO, Hermelin to resign from board
Fierce Pharma
Wednesday, November 17, 2010 - 12:50pm
tags:
KV Pharmaceutical
Is Johnson & Johnson's Cash Flow Just For Show?
Motley Fool
Wednesday, November 17, 2010 - 12:49pm
tags:
JNJ
Why Roche’s CEO Is Wrong to Blame Obamacare for 4,800 Layoffs
BNET Pharma
Wednesday, November 17, 2010 - 12:04pm
tags:
Roche, Severin Schwan, healthcare reform, layoffs, Tamiflu
Why Nile Therapeutics May Succeed Where J&J Failed
Seeking Alpha
Wednesday, November 17, 2010 - 12:01pm
tags:
JNJ, Nile Therapeutics, Natrecor
Big Boost for Human Genome Sciences Stock Likely
Minyanville
Wednesday, November 17, 2010 - 11:47am
tags:
Benlysta, Human Genome Sciences, lupus, FDA
Actelion shares surge (again) as M&A buzz hits fever pitch
Fierce Biotech
Wednesday, November 17, 2010 - 11:46am
tags:
Actelion, M&A, Amgen
The Axe Finally Falls: Roche To Cut 4,800 Jobs
Pharmalot
Wednesday, November 17, 2010 - 11:45am
tags:
Roche, Genentech, layoffs
Drugmaker's Acquisitions to Weigh on Credit Ratings, Moody's Analysts Say
Bloomberg
Wednesday, November 17, 2010 - 11:44am
tags:
M&A, credit rating, Pfizer, King, Crucell, JNJ
Pfizer Unit Downplayed Prempro’s Risks, Lawyer Says
Bloomberg
Wednesday, November 17, 2010 - 11:42am
tags:
Pfizer, Prempro, Wyeth, lawsuits, HRT
FDA Panel Backs Human Genome's Lupus Drug
TheStreet.com
Wednesday, November 17, 2010 - 11:42am
tags:
FDA, advisory panels, lupus, Benlysta, Human Genome Sciences
Amarin: Pending Catalysts, Potential Breakthrough
Seeking Alpha
Tuesday, November 16, 2010 - 1:24pm
tags:
Amarin
Anthera Seeks to Tap Heart Attack Market by Blocking Inflammation
Motley Fool
Tuesday, November 16, 2010 - 1:22pm
tags:
Anthera, heart attacks
Cost-Cutting at Pfizer: Layoffs and Shared Hotel Rooms Up the Misery
BNET Pharma
Tuesday, November 16, 2010 - 12:40pm
tags:
layoffs, Pfizer
Dead in the Water? Glaxo’s Fish Oil Pill and A-Fib
Seeking Alpha
Tuesday, November 16, 2010 - 12:39pm
tags:
GSK, fish oil, atrial fibrillation, Lovaza
Are Shorts Watching This Number at Qiagen?
Motley Fool
Tuesday, November 16, 2010 - 12:05pm
tags:
Qiagen
Pharmacyclics: Showing Promise
Seeking Alpha
Tuesday, November 16, 2010 - 12:03pm
tags:
Pharmacyclics, Pfizer, Protalix BioTherapeutics, Sanofi, Genzyme
Endo Plans Debt After Most Sales in Six Weeks: New Issue Alert
Bloomberg
Tuesday, November 16, 2010 - 12:00pm
tags:
Endo
Doctors say blood-clot drug race too close to call
Reuters
Tuesday, November 16, 2010 - 11:59am
tags:
blood thinners, Pradaxa, Xarelto, Bayer, JNJ, Boehringer Ingelheim
Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Bloomberg
Tuesday, November 16, 2010 - 11:57am
tags:
Eisai, Aricept, breast cancer, Eribulin
Human Genome: FDA Panel Live Blog
TheStreet.com
Tuesday, November 16, 2010 - 11:56am
tags:
Human Genome Sciences, FDA, advisory panels, Benlysta

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.